Teligent, Inc. (TLGT) Receives Average Rating of “Hold” from Brokerages
Shares of Teligent, Inc. (NASDAQ:TLGT) have been assigned an average recommendation of “Hold” from the seven research firms that are currently covering the stock. One investment analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation, one has given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year target price among brokers that have updated their coverage on the stock in the last year is $9.67.
A number of research analysts recently weighed in on the company. Zacks Investment Research downgraded Teligent from a “buy” rating to a “sell” rating in a research note on Wednesday, November 2nd. Roth Capital set a $10.00 price target on Teligent and gave the stock a “buy” rating in a research note on Friday, October 28th.
ILLEGAL ACTIVITY WARNING: This article was first posted by Daily Political and is the sole property of of Daily Political. If you are viewing this article on another publication, it was illegally copied and republished in violation of United States & international trademark and copyright laws. The correct version of this article can be read at http://www.dailypolitical.com/2017/01/13/teligent-inc-tlgt-receives-average-rating-of-hold-from-brokerages.html.
Shares of Teligent (NASDAQ:TLGT) traded up 2.64% on Friday, hitting $7.00. The stock had a trading volume of 290,660 shares. The company has a 50-day moving average of $6.96 and a 200 day moving average of $7.43. The company’s market capitalization is $371.88 million. Teligent has a 52 week low of $4.46 and a 52 week high of $8.66.
Teligent (NASDAQ:TLGT) last posted its quarterly earnings results on Thursday, October 27th. The company reported $0.01 earnings per share for the quarter, topping analysts’ consensus estimates of $0.00 by $0.01. Teligent had a negative return on equity of 0.38% and a negative net margin of 20.85%. The business had revenue of $16.20 million for the quarter, compared to the consensus estimate of $16.90 million. Teligent’s revenue for the quarter was up 39.7% on a year-over-year basis. On average, equities research analysts predict that Teligent will post $0.06 EPS for the current year.
Several hedge funds have recently modified their holdings of the company. California Public Employees Retirement System increased its stake in shares of Teligent by 0.8% in the second quarter. California Public Employees Retirement System now owns 25,600 shares of the company’s stock valued at $183,000 after buying an additional 200 shares during the period. Rhumbline Advisers increased its stake in shares of Teligent by 0.5% in the third quarter. Rhumbline Advisers now owns 44,124 shares of the company’s stock valued at $335,000 after buying an additional 200 shares during the period. ProShare Advisors LLC increased its stake in shares of Teligent by 0.8% in the second quarter. ProShare Advisors LLC now owns 44,563 shares of the company’s stock valued at $318,000 after buying an additional 362 shares during the period. California State Teachers Retirement System increased its stake in shares of Teligent by 1.4% in the third quarter. California State Teachers Retirement System now owns 87,436 shares of the company’s stock valued at $665,000 after buying an additional 1,200 shares during the period. Finally, Alliancebernstein L.P. increased its stake in shares of Teligent by 4.9% in the second quarter. Alliancebernstein L.P. now owns 36,200 shares of the company’s stock valued at $258,000 after buying an additional 1,700 shares during the period. 66.97% of the stock is owned by hedge funds and other institutional investors.
Teligent Company Profile
Teligent, Inc, formerly IGI Laboratories, Inc, is a specialty generic pharmaceutical company. The Company markets and sells generic injectable pharmaceutical products under its own label in the United States and Canada. It provides development, formulation and manufacturing services to the pharmaceutical, over-the-counter (OTC) and cosmetic industries.
Receive News & Ratings for Teligent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teligent Inc. and related companies with MarketBeat.com's FREE daily email newsletter.